19Jun
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G BioHealth Sells Vertiflex to Boston Scientific
H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced the sale of Vertiflex to Boston Scientific. The total equity value of the sale is approximately $465 million in cash, with additional payments...
By:
McGuireWoods LLP
Related
Where does creativity fit into compliance? In more places than you think. Problem-solving, accountab...
Read More >
A federal appeals court ruled yesterday that the 2012 guidance document from the Equal Employment Op...
Read More >
In this episode, we interview Matthew Maletta, executive vice president and chief legal officer of E...
Read More >
“What did I do wrong?” and “Am I doing this correctly?” are frequent questions from clients rega...
Read More >
There has been a lot of talk about how much more pro-business the U.S. Department of Labor was going...
Read More >
Surprisingly, in the midst of the COVID-19 emergency, final regulations under Section 901(m) were pu...
Read More >